Back
ESC Premium Access

Transcatheter aortic valve replacement alters expression levels of circulating myocardial microRNAs

Session: Poster session 1 - Risk stratification and prognosis after TAVI
Topic: Aortic valve disease
Speaker: Doctor F. Jansen (Bonn, DE)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Felix Jansen

University hospital Bonn, Bonn (Germany)
1 follower

10 more presentations in this session

Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.

Speaker: Doctor M. Perrone (Rome, IT)

Access
Like
Thumbnail

Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI

Speaker: Doctor H. Hioki (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

Cardiac biomarkers and clinical scores for risk stratification in patients with severe symptomatic aortic stenosis undergoing TAVI. Which ranks first now?

Speaker: Mrs A. Stundl (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Peri-procedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after tavi

Speaker: Mrs A. Stundl (Bonn, DE)

Access
Abstract
Slides
Like
Thumbnail

Impact of diastolic dysfunction severity on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement

Speaker: Professor R. Waksman (Washington, DC, US)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 1 - Risk stratification and prognosis after TAVI

Speakers: Doctor F. Jansen, Doctor M. Perrone, Doctor H. Hioki, Mrs A. Stundl, Mrs A. Stundl...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources